marketcap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Financial Ratios 2011-2025 | CSII
Annual Financial Ratios Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.9 | -60.8 | -51.6 | -6050.9 | 648.8 | -577.0 | -11.4 | -28.7 | -22.9 | -17.8 | -9.9 | -21.4 |
P/S |
2.5 | 3.1 | 5.9 | 6.2 | 5.1 | 5.0 | 3.6 | 5.2 | 5.9 | 4.1 | 2.0 | 3.0 |
EPS |
-0.9 | -0.3 | -0.8 | -0.0 | 0.1 | -0.1 | -1.7 | -1.0 | -1.2 | -1.1 | -0.9 | -0.7 |
EV (Enterprise Value) |
595 M | 826 M | 1.29 B | 1.54 B | 1.06 B | 1 B | 619 M | 891 M | 713 M | 389 M | 162 M | 242 M |
EBITDA per Share |
-0.82 | -0.23 | -0.7 | 0.0782 | 0.186 | 0.0801 | -1.28 | -0.961 | -1.14 | -0.989 | -0.754 | -0.508 |
EV/EBITDA |
-93.5 | -34.4 | 560.4 | 161.2 | 357.2 | -13.8 | -28.3 | -21.3 | -17.3 | -10.9 | -28.3 | |
PEG |
0.11 | 0.28 | 0.26 | 50.69 | 3.49 | -5.98 | 0.17 | -1.71 | 1.82 | 0.92 | 0.3 | -0.38 |
P/B |
2.4 | 3.0 | 5.2 | 10.4 | 8.3 | 8.7 | 6.3 | 6.8 | 5.3 | 6.4 | 5.2 | 11.0 |
P/CF |
-24.2 | -922.5 | -110.1 | 231.9 | 168.2 | 58.2 | -22.6 | -21.6 | -20.1 | -32.3 | -13.5 | -23.6 |
ROE % |
-14.80 | -4.95 | -10.13 | -0.17 | 1.27 | -1.51 | -55.53 | -23.54 | -23.21 | -35.97 | -52.16 | -51.42 |
ROA % |
-11.45 | -3.81 | -8.02 | -0.12 | 0.84 | -0.92 | -39.34 | -19.16 | -19.40 | -24.81 | -26.60 | -23.79 |
ROCE % |
-14.35 | -4.40 | -9.96 | -0.47 | 1.35 | -1.01 | -42.76 | -23.07 | -22.01 | -30.10 | -31.95 | -27.90 |
Current Ratio |
4.4 | 4.3 | 4.8 | 4.3 | 4.5 | 3.9 | 3.0 | 4.5 | 5.5 | 4.0 | 3.2 | 2.7 |
DSO |
61.6 | 46.0 | 47.2 | 53.0 | 52.5 | 50.7 | 47.4 | 62.0 | 57.1 | 51.7 | 60.4 | 61.4 |
DIO |
192.4 | 179.2 | 171.3 | 138.2 | 153.5 | 156.4 | 179.7 | 129.0 | 151.6 | 93.5 | 134.1 | 130.5 |
DPO |
81.8 | 76.4 | 85.1 | 85.7 | 96.5 | 99.4 | 87.7 | 90.2 | 149.3 | 108.2 | 106.6 | 116.2 |
Operating Cycle |
254.0 | 225.2 | 218.5 | 191.2 | 206.0 | 207.1 | 227.1 | 191.0 | 208.7 | 145.2 | 194.5 | 191.9 |
Cash Conversion Cycle |
172.2 | 148.7 | 133.4 | 105.5 | 109.5 | 107.7 | 139.4 | 100.8 | 59.4 | 37.0 | 87.9 | 75.7 |
All numbers in USD currency
Quarterly Financial Ratios Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.2 | -0.27 | -0.47 | -0.25 | -0.23 | -0.22 | -0.45 | -0.15 | - | -0.05 | - | -0.08 | -0.1 | -0.17 | -0.1 | -0.17 | 0.01 | -0.09 | 0.01 | -0.09 | -0.01 | -0.06 | -0.01 | -0.05 | 0.03 | -0.06 | 0.03 | -0.06 | -0.47 | -0.41 | -0.47 | -0.41 | -0.17 | -0.26 | -0.17 | -0.26 | -0.32 | -0.29 | -0.32 | -0.29 | -0.28 | -0.69 | -0.28 | -0.26 | -0.23 | -0.22 | -0.23 | -0.22 |
EBITDA per Share |
-0.21 | -0.25 | -0.44 | -0.24 | -0.21 | -0.18 | -0.38 | -0.14 | 0.02 | -0.02 | 0.05 | -0.07 | -0.09 | -0.15 | -0.06 | -0.15 | 0.01 | -0.06 | 0.06 | -0.06 | -0.01 | -0.02 | 0.05 | -0.02 | 0.03 | -0.03 | 0.09 | -0.03 | -0.47 | -0.38 | -0.41 | -0.38 | -0.17 | -0.25 | -0.14 | -0.25 | -0.28 | -0.26 | -0.28 | -0.32 | -0.25 | -0.29 | -0.25 | -0.26 | -0.21 | -0.17 | -0.22 | -0.18 |
ROE % |
-18.92 | -19.08 | -17.96 | -17.03 | -16.49 | -13.06 | -10.56 | -4.09 | -2.83 | -5.18 | -6.78 | -9.14 | -11.19 | -8.46 | -5.73 | -3.00 | -1.09 | -1.78 | -3.78 | -4.47 | -3.96 | -2.69 | -2.85 | -1.49 | -1.68 | -15.12 | -23.46 | -35.37 | -43.04 | -34.10 | -29.48 | -22.08 | -17.98 | -19.96 | -25.60 | -35.08 | -40.58 | -54.82 | -85.68 | -90.64 | -95.92 | -95.02 | -69.51 | -70.71 | -72.36 | -16.53 | -19.11 | -17.84 |
ROA % |
-14.66 | -14.87 | -14.06 | -13.31 | -12.77 | -10.04 | -8.06 | -3.08 | -1.95 | -3.45 | -4.41 | -5.95 | -7.28 | -5.53 | -3.72 | -1.92 | -0.70 | -1.15 | -2.43 | -2.89 | -2.49 | -1.61 | -1.92 | -0.97 | -1.26 | -11.94 | -18.77 | -28.35 | -34.78 | -27.68 | -24.02 | -18.07 | -14.85 | -16.71 | -19.87 | -25.91 | -28.91 | -34.31 | -46.92 | -47.12 | -47.85 | -45.62 | -33.33 | -33.04 | -33.04 | -7.99 | -8.84 | -8.25 |
ROCE % |
-19.66 | -19.39 | -17.98 | -16.34 | -14.68 | -11.28 | -8.81 | -2.56 | -2.32 | -4.78 | -8.30 | -10.76 | -13.02 | -10.39 | -8.39 | -5.76 | -3.80 | -4.30 | -3.62 | -4.12 | -3.36 | -2.17 | -2.53 | -1.23 | -1.63 | -15.08 | -23.40 | -35.33 | -42.97 | -34.03 | -29.41 | -22.01 | -17.90 | -19.15 | -23.25 | -29.86 | -33.67 | -41.78 | -44.91 | -46.17 | -48.47 | -45.27 | -41.84 | -42.12 | -40.44 | -9.33 | -11.59 | -9.82 |
Current Ratio |
4.3 | 4.5 | 4.4 | 4.6 | 4.9 | 4.8 | 4.3 | 4.3 | 4.7 | 4.7 | 4.8 | 2.9 | 2.8 | 2.9 | 3.1 | 3.1 | 3.0 | 3.0 | 3.0 | 3.0 | 2.9 | 2.7 | 2.6 | 2.6 | 3.4 | 3.9 | 3.4 | 3.4 | 5.0 | 5.1 | 5.4 | 5.4 | 5.6 | 5.4 | 6.1 | 6.1 | 7.3 | 3.2 | 3.2 | 3.2 | 2.1 | 1.9 | 2.0 | 2.0 | 1.7 | 1.9 | 1.9 | 1.9 |
DSO |
59.8 | 61.1 | 28.0 | 56.5 | 55.1 | 59.8 | 31.1 | 52.3 | 44.4 | 41.6 | 39.9 | 49.7 | 47.0 | 50.0 | 48.1 | 46.6 | 45.6 | 49.9 | 47.3 | 47.9 | 47.8 | 51.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
195.6 | 198.1 | 87.5 | 199.1 | 163.6 | 208.7 | 91.1 | 211.0 | 202.1 | 206.5 | 169.7 | 170.0 | 136.2 | 135.2 | 120.1 | 135.9 | 150.2 | 149.7 | 132.0 | 146.7 | 165.4 | 168.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
83.6 | 85.1 | 36.3 | 80.5 | 64.1 | 86.0 | 39.6 | 90.3 | 88.8 | 90.6 | 81.2 | 111.2 | 98.7 | 87.5 | 74.5 | 87.1 | 103.4 | 101.2 | 83.0 | 87.0 | 97.9 | 106.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
255.3 | 259.2 | 115.5 | 255.5 | 218.7 | 268.4 | 122.2 | 263.4 | 246.5 | 248.1 | 209.6 | 219.7 | 183.3 | 185.2 | 168.2 | 182.5 | 195.8 | 199.6 | 179.3 | 194.6 | 213.2 | 219.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
171.7 | 174.2 | 79.2 | 175.1 | 154.5 | 182.4 | 82.5 | 173.1 | 157.7 | 157.4 | 128.4 | 108.5 | 84.6 | 97.7 | 93.8 | 95.4 | 92.4 | 98.5 | 96.3 | 107.7 | 115.3 | 113.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Cardiovascular Systems, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Medical devices industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
$ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
$ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
$ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Lianluo Smart Limited
LLIT
|
$ 9.22 | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
$ 3.05 | -5.86 % | $ 30.6 M | USA |
 |
FONAR Corporation
FONR
|
$ 15.1 | 2.72 % | $ 99 M | USA |
 |
Neovasc
NVCN
|
$ 30.03 | - | $ 111 M |  Canada |
 |
Apollo Endosurgery
APEN
|
$ 10.0 | - | $ 475 M | USA |
 |
Integer Holdings Corporation
ITGR
|
$ 69.02 | 1.11 % | $ 2.32 B | USA |
 |
Titan Medical
TMDI
|
$ 0.14 | -26.32 % | $ 19.6 M | Canada |
 |
OrthoPediatrics Corp.
KIDS
|
$ 16.81 | -1.18 % | $ 388 M | USA |
 |
Pulmonx Corporation
LUNG
|
$ 1.95 | 1.56 % | $ 76.3 M | USA |
 |
Medtronic PLC
MDT
|
$ 92.46 | 0.28 % | $ 119 B | USA |
 |
Viveve Medical
VIVE
|
$ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Invacare Corporation
IVC
|
$ 0.66 | - | $ 24.7 M | USA |
 |
Abiomed
ABMD
|
$ 381.02 | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
$ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
Myomo
MYO
|
$ 0.91 | 6.61 % | $ 6.42 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
$ 5.28 | 1.15 % | $ 34.5 M | USA |
 |
CryoLife, Inc.
CRY
|
$ 17.84 | -4.14 % | $ 702 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
$ 24.04 | - | $ 1.77 B | USA |
 |
Soliton, Inc.
SOLY
|
$ 20.12 | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
$ 10.38 | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
$ 30.65 | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
$ 26.54 | - | $ 462 M | USA |
 |
Quanterix Corporation
QTRX
|
$ 5.11 | 3.34 % | $ 192 M | USA |
 |
AVITA Medical
RCEL
|
$ 3.96 | 4.91 % | $ 102 M |  Australia |
 |
ShockWave Medical
SWAV
|
$ 334.75 | - | $ 12.3 B | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
$ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
$ 2.64 | 1.54 % | $ 468 M | USA |
 |
Intersect ENT, Inc.
XENT
|
$ 28.24 | - | $ 955 M | USA |
 |
STRATA Skin Sciences
SSKN
|
$ 1.68 | 2.44 % | $ 58.3 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
$ 70.98 | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
$ 0.13 | -13.19 % | $ 166 K | USA |
 |
Eargo
EAR
|
$ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
$ 8.61 | -0.35 % | $ 245 M | USA |
 |
SmileDirectClub
SDC
|
$ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
ThermoGenesis Holdings
THMO
|
$ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
$ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
$ 16.44 | 3.98 % | $ 444 M | USA |
 |
Surgalign Holdings
SRGA
|
$ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
$ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
$ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
NuVasive
NUVA
|
$ 39.75 | - | $ 2.07 B | USA |
 |
Cutera
CUTR
|
$ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
$ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
$ 1.27 | 6.72 % | $ 34 M | USA |
 |
Globus Medical
GMED
|
$ 86.3 | 2.87 % | $ 11.7 B | USA |
 |
Viemed Healthcare
VMD
|
$ 6.39 | 0.31 % | $ 245 M | USA |